Eck, S L <br/><br/>
Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.  [electronic resource] 

 -  Human gene therapy  Aug 1996 
 - 1465-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/hum.1996.7.12-1465  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae Infections--drug therapy<br/>Adenoviruses, Human--genetics<br/>Adult<br/>Aged<br/>Animals<br/>Antiviral Agents--pharmacology<br/>Astrocytoma--radiotherapy<br/>Brain Neoplasms--radiotherapy<br/>Clinical Protocols<br/>Combined Modality Therapy<br/>Defective Viruses--genetics<br/>Female<br/>Ganciclovir--pharmacology<br/>Genetic Therapy<br/>Genetic Vectors--administration & dosage<br/>Glioblastoma--radiotherapy<br/>Humans<br/>Informed Consent<br/>Injections, Intralesional<br/>Male<br/>Mice<br/>Middle Aged<br/>Neoplasm Recurrence, Local--therapy<br/>Neoplastic Stem Cells--drug effects<br/>Palliative Care<br/>Patient Selection<br/>Primates<br/>Rats<br/>Recombinant Fusion Proteins--antagonists & inhibitors<br/>Safety<br/>Simplexvirus--genetics<br/>Thymidine Kinase--antagonists & inhibitors<br/>Transfection<br/>Viral Proteins--antagonists & inhibitors